Views & Analysis Rethinking drug discovery George Underwood speaks to R&D veteran Dr Paul-Peter Tak about how the drug discovery model needs to change.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
